Financhill
Back

Editas Medicine Vs. Vertex Pharmaceuticals Industry Stock Comparison

Sell
38

EDIT
Editas Medicine

Last Price:
3.39
Seasonality Move:
22%
Sell
41

VRTX
Vertex Pharmaceuticals

Last Price:
455.34
Seasonality Move:
5.22%
Sell
38
Editas Medicine (EDIT) is a Sell

Is Editas Medicine a Buy, Sell or Hold?

  • The current Editas Medicine [EDIT] share price is $3.38. The Score for EDIT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • EDIT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Vertex Pharmaceuticals (VRTX) is a Sell

Is Vertex Pharmaceuticals a Buy, Sell or Hold?

  • The current Vertex Pharmaceuticals [VRTX] share price is $455.31. The Score for VRTX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • VRTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EDIT Stock Price Chart

What is Editas Medicine's stock price today?

  • The Editas Medicine share price today is $3.38
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDIT is experiencing slight buying pressure.

VRTX Stock Price Chart

What is Vertex Pharmaceuticals's stock price today?

  • The Vertex Pharmaceuticals share price today is $455.31
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRTX is experiencing slight selling pressure.

EDIT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.19 Sell
Relative Strength Index (14 RSI): 39.94 Sell
Chaikin Money Flow: 457652 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.38 - 3.82) Sell
Bollinger Bands (100): (3.8 - 5.48) Sell

VRTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -5.49 Sell
Relative Strength Index (14 RSI): 38.19 Sell
Chaikin Money Flow: -19753 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (460.67 - 481.05) Sell
Bollinger Bands (100): (458.48 - 489.66) Sell

EDIT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.36 Buy
20-day SMA: 3.6 Sell
50-day SMA: 3.96 Sell
200-day SMA: 6.19 Sell
8-day EMA: 3.38 Buy
20-day EMA: 3.55 Sell
50-day EMA: 3.96 Sell
200-day EMA: 5.77 Sell

VRTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 461.71 Sell
20-day SMA: 469.24 Sell
50-day SMA: 476.71 Sell
200-day SMA: 444.79 Buy
8-day EMA: 461.33 Sell
20-day EMA: 467.3 Sell
50-day EMA: 472 Sell
200-day EMA: 442.99 Buy

Editas Medicine Earnings Growth & EDIT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.66 per share, and an increase next year of $0.19 per share.

Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $1.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $14.90 per share, and an increase next year of $18.27 per share.

Editas Medicine Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Vertex Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):